nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—CYP2C8—Mometasone—systemic scleroderma	0.101	0.148	CbGbCtD
Quinine—SLCO1A2—Prednisone—systemic scleroderma	0.0806	0.118	CbGbCtD
Quinine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0529	0.0774	CbGbCtD
Quinine—CYP1A2—Leflunomide—systemic scleroderma	0.0504	0.0739	CbGbCtD
Quinine—ABCB1—Lisinopril—systemic scleroderma	0.0462	0.0677	CbGbCtD
Quinine—CYP2C9—Leflunomide—systemic scleroderma	0.0454	0.0666	CbGbCtD
Quinine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0419	0.0613	CbGbCtD
Quinine—SLCO1A2—Methotrexate—systemic scleroderma	0.0404	0.0592	CbGbCtD
Quinine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0403	0.059	CbGbCtD
Quinine—ABCB1—Captopril—systemic scleroderma	0.0346	0.0507	CbGbCtD
Quinine—CYP2D6—Captopril—systemic scleroderma	0.0326	0.0478	CbGbCtD
Quinine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0272	0.0399	CbGbCtD
Quinine—CYP2C19—Prednisone—systemic scleroderma	0.027	0.0395	CbGbCtD
Quinine—ABCB1—Prednisone—systemic scleroderma	0.0218	0.0319	CbGbCtD
Quinine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0163	0.0239	CbGbCtD
Quinine—CYP3A4—Prednisone—systemic scleroderma	0.0131	0.0191	CbGbCtD
Quinine—ABCB1—Methotrexate—systemic scleroderma	0.0109	0.016	CbGbCtD
Quinine—CYP2C9—cardial valve—systemic scleroderma	0.00681	0.347	CbGeAlD
Quinine—KCNN4—smooth muscle tissue—systemic scleroderma	0.00117	0.0597	CbGeAlD
Quinine—KCNN4—digestive system—systemic scleroderma	0.000925	0.0471	CbGeAlD
Quinine—KCNN4—tendon—systemic scleroderma	0.000881	0.0448	CbGeAlD
Quinine—KCNN4—lung—systemic scleroderma	0.000773	0.0393	CbGeAlD
Quinine—SLC22A2—digestive system—systemic scleroderma	0.000698	0.0355	CbGeAlD
Quinine—SLC22A4—digestive system—systemic scleroderma	0.000518	0.0264	CbGeAlD
Quinine—SLC22A4—tendon—systemic scleroderma	0.000493	0.0251	CbGeAlD
Quinine—SLCO1A2—digestive system—systemic scleroderma	0.000475	0.0242	CbGeAlD
Quinine—SLC22A4—lung—systemic scleroderma	0.000433	0.022	CbGeAlD
Quinine—ABCB1—blood vessel—systemic scleroderma	0.00043	0.0219	CbGeAlD
Quinine—SLC22A5—skin of body—systemic scleroderma	0.000429	0.0218	CbGeAlD
Quinine—SLCO1A2—lung—systemic scleroderma	0.000397	0.0202	CbGeAlD
Quinine—CYP1A1—skin of body—systemic scleroderma	0.000383	0.0195	CbGeAlD
Quinine—CYP2C19—digestive system—systemic scleroderma	0.00038	0.0194	CbGeAlD
Quinine—SLC22A5—digestive system—systemic scleroderma	0.000343	0.0174	CbGeAlD
Quinine—Palpitations—Lisinopril—systemic scleroderma	0.000328	0.0011	CcSEcCtD
Quinine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000327	0.0011	CcSEcCtD
Quinine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000326	0.0011	CcSEcCtD
Quinine—SLC22A5—tendon—systemic scleroderma	0.000326	0.0166	CbGeAlD
Quinine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000326	0.0011	CcSEcCtD
Quinine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00109	CcSEcCtD
Quinine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000325	0.00109	CcSEcCtD
Quinine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000324	0.00109	CcSEcCtD
Quinine—Muscular weakness—Prednisone—systemic scleroderma	0.000323	0.00108	CcSEcCtD
Quinine—Visual disturbance—Methotrexate—systemic scleroderma	0.000323	0.00108	CcSEcCtD
Quinine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000322	0.00108	CcSEcCtD
Quinine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000321	0.00108	CcSEcCtD
Quinine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00032	0.00108	CcSEcCtD
Quinine—Chest pain—Lisinopril—systemic scleroderma	0.000316	0.00106	CcSEcCtD
Quinine—Myalgia—Lisinopril—systemic scleroderma	0.000316	0.00106	CcSEcCtD
Quinine—Dyspnoea—Leflunomide—systemic scleroderma	0.000314	0.00106	CcSEcCtD
Quinine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000314	0.00106	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000314	0.00105	CcSEcCtD
Quinine—CYP1A2—digestive system—systemic scleroderma	0.000311	0.0158	CbGeAlD
Quinine—Vomiting—Mometasone—systemic scleroderma	0.000309	0.00104	CcSEcCtD
Quinine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000307	0.00103	CcSEcCtD
Quinine—Rash—Mometasone—systemic scleroderma	0.000307	0.00103	CcSEcCtD
Quinine—Asthenia—Captopril—systemic scleroderma	0.000307	0.00103	CcSEcCtD
Quinine—Dermatitis—Mometasone—systemic scleroderma	0.000307	0.00103	CcSEcCtD
Quinine—CYP1A1—digestive system—systemic scleroderma	0.000306	0.0156	CbGeAlD
Quinine—Decreased appetite—Leflunomide—systemic scleroderma	0.000306	0.00103	CcSEcCtD
Quinine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000306	0.00103	CcSEcCtD
Quinine—Confusional state—Lisinopril—systemic scleroderma	0.000305	0.00103	CcSEcCtD
Quinine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000305	0.00103	CcSEcCtD
Quinine—Headache—Mometasone—systemic scleroderma	0.000305	0.00102	CcSEcCtD
Quinine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00102	CcSEcCtD
Quinine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000304	0.00102	CcSEcCtD
Quinine—Oedema—Lisinopril—systemic scleroderma	0.000303	0.00102	CcSEcCtD
Quinine—Pruritus—Captopril—systemic scleroderma	0.000302	0.00102	CcSEcCtD
Quinine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0003	0.00101	CcSEcCtD
Quinine—CYP3A5—digestive system—systemic scleroderma	0.000299	0.0152	CbGeAlD
Quinine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000299	0.001	CcSEcCtD
Quinine—Shock—Lisinopril—systemic scleroderma	0.000298	0.001	CcSEcCtD
Quinine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000998	CcSEcCtD
Quinine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000296	0.000996	CcSEcCtD
Quinine—Neutropenia—Prednisone—systemic scleroderma	0.000296	0.000994	CcSEcCtD
Quinine—Tachycardia—Lisinopril—systemic scleroderma	0.000295	0.000993	CcSEcCtD
Quinine—Body temperature increased—Azathioprine—systemic scleroderma	0.000295	0.000991	CcSEcCtD
Quinine—Abdominal pain—Azathioprine—systemic scleroderma	0.000295	0.000991	CcSEcCtD
Quinine—CYP2C9—digestive system—systemic scleroderma	0.000295	0.015	CbGeAlD
Quinine—Skin disorder—Lisinopril—systemic scleroderma	0.000294	0.000988	CcSEcCtD
Quinine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000293	0.000983	CcSEcCtD
Quinine—Diarrhoea—Captopril—systemic scleroderma	0.000292	0.000983	CcSEcCtD
Quinine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000292	0.000982	CcSEcCtD
Quinine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000981	CcSEcCtD
Quinine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000979	CcSEcCtD
Quinine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000978	CcSEcCtD
Quinine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00029	0.000976	CcSEcCtD
Quinine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00029	0.000975	CcSEcCtD
Quinine—Nausea—Mometasone—systemic scleroderma	0.000289	0.000971	CcSEcCtD
Quinine—Anorexia—Lisinopril—systemic scleroderma	0.000288	0.00097	CcSEcCtD
Quinine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000288	0.000968	CcSEcCtD
Quinine—Ataxia—Methotrexate—systemic scleroderma	0.000287	0.000966	CcSEcCtD
Quinine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000965	CcSEcCtD
Quinine—SLC22A5—lung—systemic scleroderma	0.000286	0.0146	CbGeAlD
Quinine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000286	0.00096	CcSEcCtD
Quinine—Hypotension—Lisinopril—systemic scleroderma	0.000283	0.000951	CcSEcCtD
Quinine—Dizziness—Captopril—systemic scleroderma	0.000283	0.00095	CcSEcCtD
Quinine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000282	0.000948	CcSEcCtD
Quinine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000946	CcSEcCtD
Quinine—Urticaria—Leflunomide—systemic scleroderma	0.00028	0.000941	CcSEcCtD
Quinine—CYP2E1—digestive system—systemic scleroderma	0.000279	0.0142	CbGeAlD
Quinine—Abdominal pain—Leflunomide—systemic scleroderma	0.000278	0.000936	CcSEcCtD
Quinine—Body temperature increased—Leflunomide—systemic scleroderma	0.000278	0.000936	CcSEcCtD
Quinine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000277	0.000931	CcSEcCtD
Quinine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00093	CcSEcCtD
Quinine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00093	CcSEcCtD
Quinine—Breast disorder—Methotrexate—systemic scleroderma	0.000276	0.000928	CcSEcCtD
Quinine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000276	0.000927	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000275	0.000925	CcSEcCtD
Quinine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000275	0.000924	CcSEcCtD
Quinine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000275	0.000924	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000923	CcSEcCtD
Quinine—Vomiting—Captopril—systemic scleroderma	0.000272	0.000913	CcSEcCtD
Quinine—Dyspnoea—Lisinopril—systemic scleroderma	0.00027	0.000907	CcSEcCtD
Quinine—Rash—Captopril—systemic scleroderma	0.000269	0.000906	CcSEcCtD
Quinine—Dermatitis—Captopril—systemic scleroderma	0.000269	0.000905	CcSEcCtD
Quinine—Headache—Captopril—systemic scleroderma	0.000268	0.0009	CcSEcCtD
Quinine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000899	CcSEcCtD
Quinine—CYP2E1—tendon—systemic scleroderma	0.000266	0.0135	CbGeAlD
Quinine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000266	0.000893	CcSEcCtD
Quinine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000266	0.000893	CcSEcCtD
Quinine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000891	CcSEcCtD
Quinine—Asthma—Methotrexate—systemic scleroderma	0.000264	0.000888	CcSEcCtD
Quinine—Decreased appetite—Lisinopril—systemic scleroderma	0.000263	0.000884	CcSEcCtD
Quinine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000261	0.000878	CcSEcCtD
Quinine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000877	CcSEcCtD
Quinine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000874	CcSEcCtD
Quinine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000873	CcSEcCtD
Quinine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000259	0.000872	CcSEcCtD
Quinine—CYP1A2—lung—systemic scleroderma	0.000259	0.0132	CbGeAlD
Quinine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00087	CcSEcCtD
Quinine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000866	CcSEcCtD
Quinine—Bradycardia—Prednisone—systemic scleroderma	0.000258	0.000866	CcSEcCtD
Quinine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000862	CcSEcCtD
Quinine—CYP1A1—lung—systemic scleroderma	0.000256	0.013	CbGeAlD
Quinine—Diarrhoea—Azathioprine—systemic scleroderma	0.000255	0.000858	CcSEcCtD
Quinine—Haemoglobin—Prednisone—systemic scleroderma	0.000254	0.000855	CcSEcCtD
Quinine—Nausea—Captopril—systemic scleroderma	0.000254	0.000853	CcSEcCtD
Quinine—Haemorrhage—Prednisone—systemic scleroderma	0.000253	0.00085	CcSEcCtD
Quinine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00085	CcSEcCtD
Quinine—Asthenia—Leflunomide—systemic scleroderma	0.000253	0.000849	CcSEcCtD
Quinine—Pancytopenia—Methotrexate—systemic scleroderma	0.000251	0.000843	CcSEcCtD
Quinine—CYP3A5—lung—systemic scleroderma	0.00025	0.0127	CbGeAlD
Quinine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000249	0.000838	CcSEcCtD
Quinine—Pruritus—Leflunomide—systemic scleroderma	0.000249	0.000838	CcSEcCtD
Quinine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000833	CcSEcCtD
Quinine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000247	0.000832	CcSEcCtD
Quinine—Neutropenia—Methotrexate—systemic scleroderma	0.000247	0.00083	CcSEcCtD
Quinine—Dizziness—Azathioprine—systemic scleroderma	0.000247	0.000829	CcSEcCtD
Quinine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000812	CcSEcCtD
Quinine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000241	0.00081	CcSEcCtD
Quinine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000241	0.00081	CcSEcCtD
Quinine—Diarrhoea—Leflunomide—systemic scleroderma	0.000241	0.00081	CcSEcCtD
Quinine—Urticaria—Lisinopril—systemic scleroderma	0.00024	0.000808	CcSEcCtD
Quinine—Abdominal pain—Lisinopril—systemic scleroderma	0.000239	0.000804	CcSEcCtD
Quinine—Body temperature increased—Lisinopril—systemic scleroderma	0.000239	0.000804	CcSEcCtD
Quinine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000238	0.000799	CcSEcCtD
Quinine—Vomiting—Azathioprine—systemic scleroderma	0.000237	0.000797	CcSEcCtD
Quinine—Eye disorder—Prednisone—systemic scleroderma	0.000236	0.000795	CcSEcCtD
Quinine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000795	CcSEcCtD
Quinine—Rash—Azathioprine—systemic scleroderma	0.000235	0.00079	CcSEcCtD
Quinine—Dermatitis—Azathioprine—systemic scleroderma	0.000235	0.00079	CcSEcCtD
Quinine—Flushing—Prednisone—systemic scleroderma	0.000235	0.000789	CcSEcCtD
Quinine—Headache—Azathioprine—systemic scleroderma	0.000234	0.000785	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000234	0.000785	CcSEcCtD
Quinine—CYP2E1—lung—systemic scleroderma	0.000233	0.0119	CbGeAlD
Quinine—Dizziness—Leflunomide—systemic scleroderma	0.000233	0.000783	CcSEcCtD
Quinine—Renal failure—Methotrexate—systemic scleroderma	0.000232	0.000778	CcSEcCtD
Quinine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000775	CcSEcCtD
Quinine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00023	0.000773	CcSEcCtD
Quinine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00077	CcSEcCtD
Quinine—Immune system disorder—Prednisone—systemic scleroderma	0.000229	0.000768	CcSEcCtD
Quinine—Sweating—Methotrexate—systemic scleroderma	0.000226	0.000759	CcSEcCtD
Quinine—CYP3A4—digestive system—systemic scleroderma	0.000225	0.0114	CbGeAlD
Quinine—Vomiting—Leflunomide—systemic scleroderma	0.000224	0.000753	CcSEcCtD
Quinine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000223	0.00075	CcSEcCtD
Quinine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000222	0.000747	CcSEcCtD
Quinine—Rash—Leflunomide—systemic scleroderma	0.000222	0.000746	CcSEcCtD
Quinine—Dermatitis—Leflunomide—systemic scleroderma	0.000222	0.000746	CcSEcCtD
Quinine—Mental disorder—Prednisone—systemic scleroderma	0.000222	0.000745	CcSEcCtD
Quinine—Nausea—Azathioprine—systemic scleroderma	0.000222	0.000745	CcSEcCtD
Quinine—CYP2D6—digestive system—systemic scleroderma	0.000221	0.0113	CbGeAlD
Quinine—Headache—Leflunomide—systemic scleroderma	0.000221	0.000742	CcSEcCtD
Quinine—Erythema—Prednisone—systemic scleroderma	0.00022	0.00074	CcSEcCtD
Quinine—Malnutrition—Prednisone—systemic scleroderma	0.00022	0.00074	CcSEcCtD
Quinine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00022	0.000739	CcSEcCtD
Quinine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000735	CcSEcCtD
Quinine—Asthenia—Lisinopril—systemic scleroderma	0.000217	0.00073	CcSEcCtD
Quinine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000729	CcSEcCtD
Quinine—Pruritus—Lisinopril—systemic scleroderma	0.000214	0.00072	CcSEcCtD
Quinine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000214	0.000718	CcSEcCtD
Quinine—Haemoglobin—Methotrexate—systemic scleroderma	0.000213	0.000714	CcSEcCtD
Quinine—Rash—Mycophenolic acid—systemic scleroderma	0.000212	0.000712	CcSEcCtD
Quinine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000212	0.000711	CcSEcCtD
Quinine—Hepatitis—Methotrexate—systemic scleroderma	0.000211	0.000711	CcSEcCtD
Quinine—Haemorrhage—Methotrexate—systemic scleroderma	0.000211	0.000711	CcSEcCtD
Quinine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000708	CcSEcCtD
Quinine—Headache—Mycophenolic acid—systemic scleroderma	0.00021	0.000708	CcSEcCtD
Quinine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000705	CcSEcCtD
Quinine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000705	CcSEcCtD
Quinine—Nausea—Leflunomide—systemic scleroderma	0.000209	0.000703	CcSEcCtD
Quinine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000209	0.000702	CcSEcCtD
Quinine—Vision blurred—Prednisone—systemic scleroderma	0.000208	0.000698	CcSEcCtD
Quinine—Urethral disorder—Methotrexate—systemic scleroderma	0.000207	0.000697	CcSEcCtD
Quinine—Diarrhoea—Lisinopril—systemic scleroderma	0.000207	0.000696	CcSEcCtD
Quinine—Visual impairment—Methotrexate—systemic scleroderma	0.000204	0.000685	CcSEcCtD
Quinine—Agitation—Prednisone—systemic scleroderma	0.000202	0.00068	CcSEcCtD
Quinine—Angioedema—Prednisone—systemic scleroderma	0.000201	0.000676	CcSEcCtD
Quinine—Dizziness—Lisinopril—systemic scleroderma	0.0002	0.000673	CcSEcCtD
Quinine—Erythema multiforme—Methotrexate—systemic scleroderma	0.0002	0.000672	CcSEcCtD
Quinine—Nausea—Mycophenolic acid—systemic scleroderma	0.0002	0.000671	CcSEcCtD
Quinine—Vertigo—Prednisone—systemic scleroderma	0.000198	0.000665	CcSEcCtD
Quinine—Eye disorder—Methotrexate—systemic scleroderma	0.000198	0.000664	CcSEcCtD
Quinine—Syncope—Prednisone—systemic scleroderma	0.000198	0.000664	CcSEcCtD
Quinine—Tinnitus—Methotrexate—systemic scleroderma	0.000197	0.000663	CcSEcCtD
Quinine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000196	0.00066	CcSEcCtD
Quinine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000657	CcSEcCtD
Quinine—Loss of consciousness—Prednisone—systemic scleroderma	0.000194	0.000651	CcSEcCtD
Quinine—Vomiting—Lisinopril—systemic scleroderma	0.000192	0.000647	CcSEcCtD
Quinine—Immune system disorder—Methotrexate—systemic scleroderma	0.000191	0.000642	CcSEcCtD
Quinine—Rash—Lisinopril—systemic scleroderma	0.000191	0.000641	CcSEcCtD
Quinine—Convulsion—Prednisone—systemic scleroderma	0.000191	0.000641	CcSEcCtD
Quinine—Dermatitis—Lisinopril—systemic scleroderma	0.000191	0.000641	CcSEcCtD
Quinine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000191	0.000641	CcSEcCtD
Quinine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00019	0.00064	CcSEcCtD
Quinine—Chills—Methotrexate—systemic scleroderma	0.00019	0.000638	CcSEcCtD
Quinine—Headache—Lisinopril—systemic scleroderma	0.00019	0.000637	CcSEcCtD
Quinine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000631	CcSEcCtD
Quinine—Myalgia—Prednisone—systemic scleroderma	0.000188	0.00063	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000186	0.000626	CcSEcCtD
Quinine—Mental disorder—Methotrexate—systemic scleroderma	0.000185	0.000623	CcSEcCtD
Quinine—Erythema—Methotrexate—systemic scleroderma	0.000184	0.000619	CcSEcCtD
Quinine—Malnutrition—Methotrexate—systemic scleroderma	0.000184	0.000619	CcSEcCtD
Quinine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00061	CcSEcCtD
Quinine—Nausea—Lisinopril—systemic scleroderma	0.00018	0.000604	CcSEcCtD
Quinine—Oedema—Prednisone—systemic scleroderma	0.00018	0.000604	CcSEcCtD
Quinine—Shock—Prednisone—systemic scleroderma	0.000177	0.000594	CcSEcCtD
Quinine—Nervous system disorder—Prednisone—systemic scleroderma	0.000176	0.000593	CcSEcCtD
Quinine—Tachycardia—Prednisone—systemic scleroderma	0.000175	0.00059	CcSEcCtD
Quinine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000589	CcSEcCtD
Quinine—Skin disorder—Prednisone—systemic scleroderma	0.000175	0.000587	CcSEcCtD
Quinine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000174	0.000584	CcSEcCtD
Quinine—Vision blurred—Methotrexate—systemic scleroderma	0.000173	0.000583	CcSEcCtD
Quinine—Anorexia—Prednisone—systemic scleroderma	0.000171	0.000576	CcSEcCtD
Quinine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000567	CcSEcCtD
Quinine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000562	CcSEcCtD
Quinine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000561	CcSEcCtD
Quinine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000558	CcSEcCtD
Quinine—Vertigo—Methotrexate—systemic scleroderma	0.000165	0.000556	CcSEcCtD
Quinine—Leukopenia—Methotrexate—systemic scleroderma	0.000165	0.000554	CcSEcCtD
Quinine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000164	0.00055	CcSEcCtD
Quinine—Convulsion—Methotrexate—systemic scleroderma	0.000159	0.000536	CcSEcCtD
Quinine—ABCB1—digestive system—systemic scleroderma	0.000159	0.0081	CbGeAlD
Quinine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000529	CcSEcCtD
Quinine—Myalgia—Methotrexate—systemic scleroderma	0.000157	0.000527	CcSEcCtD
Quinine—Chest pain—Methotrexate—systemic scleroderma	0.000157	0.000527	CcSEcCtD
Quinine—Decreased appetite—Prednisone—systemic scleroderma	0.000156	0.000525	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000156	0.000523	CcSEcCtD
Quinine—Confusional state—Methotrexate—systemic scleroderma	0.000151	0.000509	CcSEcCtD
Quinine—Feeling abnormal—Prednisone—systemic scleroderma	0.000148	0.000498	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000147	0.000495	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000147	0.000494	CcSEcCtD
Quinine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000147	0.000494	CcSEcCtD
Quinine—Skin disorder—Methotrexate—systemic scleroderma	0.000146	0.00049	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000145	0.000488	CcSEcCtD
Quinine—Anorexia—Methotrexate—systemic scleroderma	0.000143	0.000481	CcSEcCtD
Quinine—Urticaria—Prednisone—systemic scleroderma	0.000143	0.00048	CcSEcCtD
Quinine—Abdominal pain—Prednisone—systemic scleroderma	0.000142	0.000478	CcSEcCtD
Quinine—Body temperature increased—Prednisone—systemic scleroderma	0.000142	0.000478	CcSEcCtD
Quinine—Hypotension—Methotrexate—systemic scleroderma	0.00014	0.000472	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000137	0.00046	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—systemic scleroderma	0.000134	0.00045	CcSEcCtD
Quinine—ABCB1—lung—systemic scleroderma	0.000133	0.00676	CbGeAlD
Quinine—Hypersensitivity—Prednisone—systemic scleroderma	0.000132	0.000445	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—systemic scleroderma	0.000131	0.000439	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00013	0.000436	CcSEcCtD
Quinine—Asthenia—Prednisone—systemic scleroderma	0.000129	0.000433	CcSEcCtD
Quinine—Pruritus—Prednisone—systemic scleroderma	0.000127	0.000427	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000124	0.000416	CcSEcCtD
Quinine—Diarrhoea—Prednisone—systemic scleroderma	0.000123	0.000413	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000123	0.000413	CcSEcCtD
Quinine—Urticaria—Methotrexate—systemic scleroderma	0.000119	0.000401	CcSEcCtD
Quinine—Dizziness—Prednisone—systemic scleroderma	0.000119	0.0004	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—systemic scleroderma	0.000119	0.000399	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—systemic scleroderma	0.000119	0.000399	CcSEcCtD
Quinine—Vomiting—Prednisone—systemic scleroderma	0.000114	0.000384	CcSEcCtD
Quinine—Rash—Prednisone—systemic scleroderma	0.000113	0.000381	CcSEcCtD
Quinine—Dermatitis—Prednisone—systemic scleroderma	0.000113	0.000381	CcSEcCtD
Quinine—Headache—Prednisone—systemic scleroderma	0.000113	0.000379	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000111	0.000372	CcSEcCtD
Quinine—Asthenia—Methotrexate—systemic scleroderma	0.000108	0.000362	CcSEcCtD
Quinine—Nausea—Prednisone—systemic scleroderma	0.000107	0.000359	CcSEcCtD
Quinine—Pruritus—Methotrexate—systemic scleroderma	0.000106	0.000357	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—systemic scleroderma	0.000103	0.000345	CcSEcCtD
Quinine—Dizziness—Methotrexate—systemic scleroderma	9.93e-05	0.000334	CcSEcCtD
Quinine—Vomiting—Methotrexate—systemic scleroderma	9.55e-05	0.000321	CcSEcCtD
Quinine—Rash—Methotrexate—systemic scleroderma	9.47e-05	0.000318	CcSEcCtD
Quinine—Dermatitis—Methotrexate—systemic scleroderma	9.46e-05	0.000318	CcSEcCtD
Quinine—Headache—Methotrexate—systemic scleroderma	9.41e-05	0.000316	CcSEcCtD
Quinine—Nausea—Methotrexate—systemic scleroderma	8.92e-05	0.0003	CcSEcCtD
